559 search results for “medieval een lacdr” in the Student website
-
Gideon KerstenFaculty of Science
-
Eveline de VliegerFaculty of Science
-
Anne-Grete MärtsonFaculty of Science
-
Imke BrunsFaculty of Science
-
Mariona Oliver LloberasFaculty of Science
-
Roy SnijckersFaculty of Science
-
Danxia ZhaoFaculty of Science
-
Koen van der MaadenFaculty of Science
-
Mikolaj SzachniewiczFaculty of Science
-
Maria XiberrasFaculty of Science
-
Pier LindenberghFaculty of Science
-
Sylvia Le DévédecFaculty of Science
-
Romy DijklandFaculty of Science
-
Barend MonsFaculty of Medicine
-
Jeroen MolenaarFaculty of Science
-
Marjo de GraauwFaculty of Science
-
Monique TjiongFaculty of Science
-
Jan van der LaanFaculty of Science
-
Dirk-Jan van den BergFaculty of Science
-
Frank SchaftenaarFaculty of Science
-
Chenlin FengFaculty of Science
-
Aole ZhengFaculty of Science
-
Bas ter BraakFaculty of Science
-
Kauthar ParkerFaculty of Science
-
Tessa HagensFaculty of Science
-
Laura de JongFaculty of Science
-
Peter BouwmanFaculty of Science
-
Piet Hein GraafFaculty of Science
-
Sophieke LemsFaculty of Science
-
Marloes van OosterhoutFaculty of Science
-
Cecilia BergonziniFaculty of Science
-
Manchu ThangaveluFaculty of Science
-
Melissa van HemertFaculty of Science
-
Jos Jonkers
Faculty of Science
-
Anne Charlotte DubbelmanFaculty of Science
-
Raju SharmaFaculty of Science
-
Marie DepuydtFaculty of Science
-
Bonan ZhaoFaculty of Science
-
Mariyana SavovaFaculty of Science
-
Catrin Lutz
Faculty of Science
-
Better treatment of skin diseases thanks to NWA grant of 11.7 million euros
Patients with skin diseases such as eczema and psoriasis, sometimes spend a lifetime searching for the right medication. To help these patients faster and better, scientists across the country are joining forces. The Next Generation ImmunoDermatology (NGID) project, with LACDR professor Robert Rissmann…
-
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
Gilles van Wezel steps down as SD of the IBL: Hubertus Irth appointed as temporary replacement
Gilles van Wezel will step down as Scientific Director (SD) of the Institute of Biology Leiden (IBL) as of June 17th. He has held this position since September 2018. Van Wezel will be temporarily succeeded by Hubertus Irth, the current SD of the Leiden Academic Centre for Drug Research (LACDR). Irth…
-
During the next pandemic, this mathematical model will speed up the search for treatment
Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…
-
Unlocking the secrets of DNA repair: Sarah’s curiosity might lead to new cancer treatments
How do cells repair their damaged DNA—and what happens when that process is hindered and cancer arises? Sarah Moser has taken a closer look during her PhD, uncovering surprising insights that could help improve future cancer treatments.
-
Remarkable PhD research: diagnosing sepsis in premature babies
How can we diagnose the life-threatening condition sepsis in premature babies as quickly and accurately as possible? That is what PhD student Manchu Thangavelu from the Leiden Academic Centre for Drug Research (LACDR) wants to figure out.
-
Minors in AI, Data & Digitialisation in Delft, Leiden and Rotterdam
The universities of Delft, Leiden and Rotterdam are working together to show their students what artificial intelligence (AI) means for their own field. Three AI minors will start in the 2022 – 2023 academic year and will answer questions such as: ‘How best can you use AI in your research discipline?’…
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
A future with tailored therapy for patients with atherosclerosis
The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.
-
Susanna de BeerFaculty of Humanities